Skip to main content

ICPE 2022 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Ning Wu

Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA

Poster(s):

(AE) Shifting Treatment Landscape and Overall Survival by PD-L1 Expression Level Among Patients with Advanced Non-Small Cell Lung Cancer (aNSCLC)
Saturday, August 27, 2022
8:00 AM – 6:00 PM CEST
(72) Trends and Disparities in Real-World Biomarker Testing and Overall Survival (OS) Among US Patients with Advanced Non-Small Cell Lung Cancer (aNSCLC), 2015–2020
Sunday, August 28, 2022
8:00 AM – 1:45 PM CEST